title: Technology Resource, Distribution, and Development Characteristics of Global Influenza Virus Vaccine: A Patent Bibliometric Analysis.
abstract: Influenza virus vaccine (IVV) is a promising research domain that is closely related to global health matters, which has been acknowledged not only by scientists and technology developers, but also by policy-makers. Meanwhile, patents encompass valuable technological information and reflect the latest technological inventions as well as the innovative capability of a nation. However, little research has examined this up-and-coming research field using patent bibliometric method. Thus, this paper (a) designs the technology classification system and search strategy for the identification of IVV; and (b) presents a longitudinal analysis of the global IVV development based on the European Patent Office (EPO) patents. Bibliometric analysis is used to rank countries, institutions, inventors and technology subfields contributing to IVV technical progress. The results show that the global trends of IVV are a multi-developing feature of variety but an uneven technical resource distribution. Although the synthetic peptide vaccine is a comparatively young field, it already demonstrates the powerful vitality and the enormous development space. With the worldwide competition increasing, all nations especially China should be looking to increase devotion, enhance capability and regard effectiveness of technological innovation.
authors.affiliation: School of Public Health, Capital Medical University, Beijing, China, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China; Beijing Municipal Science and Technology Commission, Beijing, China.
authors.forename: Ning
authors.initials: N
authors.lastname: Chen
authors.affiliation: School of Management & Economics, Beijing Institute of Technology, Beijing, China.
authors.forename: Yun
authors.initials: Y
authors.lastname: Liu
authors.affiliation: School of Management & Economics, Beijing Institute of Technology, Beijing, China.
authors.forename: Yijie
authors.initials: Y
authors.lastname: Cheng
authors.affiliation: School of Public Health, Capital Medical University, Beijing, China, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China.
authors.forename: Long
authors.initials: L
authors.lastname: Liu
authors.affiliation: School of Management & Economics, Beijing Institute of Technology, Beijing, China.
authors.forename: Zhe
authors.initials: Z
authors.lastname: Yan
authors.affiliation: School of Public Health, Capital Medical University, Beijing, China, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China.
authors.forename: Lixin
authors.initials: L
authors.lastname: Tao
authors.affiliation: School of Public Health, Capital Medical University, Beijing, China, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China.
authors.forename: Xiuhua
authors.initials: X
authors.lastname: Guo
authors.affiliation: School of Public Health, Capital Medical University, Beijing, China, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China.
authors.forename: Yanxia
authors.initials: Y
authors.lastname: Luo
authors.affiliation: School of Public Health, Capital Medical University, Beijing, China, Beijing Municipal Key Laboratory of Clinical Epidemiology, Beijing, China; Beijing Municipal Science and Technology Commission, Beijing, China.
authors.forename: Aoshuang
authors.initials: A
authors.lastname: Yan
mesh_terms: D000288:Administrative Personnel; D015706:Bibliometrics; D007252:Influenza Vaccines; D038622:Internationality; D009975:Orthomyxoviridae / Q000276:immunology*; D010330:Patents as Topic / Q000706:statistics & numerical data*; D012108:Research Personnel; D013672:Technology / Q000706:statistics & numerical data*
chemical_list: D007252:Influenza Vaccines